The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730
Organofluorine Chemistry: Principles and Commercial Applications
(1994) · doi:10.1007/978-1-4899-1202-2 · Cited by 1,691
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
Fluorinated pyrimidines, a new class of tumour-inhibitory compounds
HEIDELBERGER, C., CHAUDHURI, N. K., DANNEBERG, P., MOOREN, D., GRIESBACH, L., DUSCHINSKY, R., SCHNITZER, R. J., PLEVEN, E., & SCHEINER, J. (1957) · Nature · doi:10.1038/179663a0 · Cited by 1,603
Fluorine in medicinal chemistry: A review of anti-cancer agents
Isanbor, C., & O’Hagan, D. (2006) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2006.01.011 · Cited by 1,120
Organofluorine chemistry : principles and commercial applications
Banks, R. E., SMART, B. E., & Tatlow, J. C. (1994) · Springer eBooks · Cited by 1,105
Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
Kim, D., Wang, L., Beconi, M., Eiermann, G. J., Fisher, M. H., He, H., Hickey, G. J., Kowalchick, J. E., Leiting, B., Lyons, K., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493156 · Cited by 822
Wong, D. T., Bymaster, F. P., & Engleman, E. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00209-o · Cited by 647
PPAR : a dagger in the heart of the metabolic syndrome
Barish, G. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27955 · Cited by 641
Oxazolidinone Structure–Activity Relationships Leading to Linezolid
Barbachyn, M. R., & Ford, C. W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200528 · Cited by 553
Molecular characterization of the melanin-concentrating-hormone receptor
Saito, Y., Nothacker, H.-P., Wang, Z., Lin, S. H. S., Leslie, F., & Civelli, O. (1999) · Nature · doi:10.1038/22321 · Cited by 541
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
Okamoto, H., Yonemori, F., Wakitani, K., Minowa, T., Maeda, K., & Shinkai, H. (2000) · Nature · doi:10.1038/35018119 · Cited by 531
HERMAN, G., STEVENS, C., VANDYCK, K., BERGMAN, A., YI, B., DESMET, M., SNYDER, K., HILLIARD, D., TANEN, M., & TANAKA, W. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.09.002 · Cited by 519
Borowsky, B., Durkin, M. M., Ogozalek, K., Marzabadi, M. R., DeLeon, J., Heurich, R., Lichtblau, H., Shaposhnik, Z., Daniewska, I., Blackburn, T. P., et al. (2002) · Nature Medicine · doi:10.1038/nm741 · Cited by 506
Andersson, M. I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg212 · Cited by 503
Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1
Chambers, J., Ames, R. S., Bergsma, D., Muir, A., Fitzgerald, L. R., Hervieu, G., Dytko, G. M., Foley, J. J., Martin, J., Liu, W.-S., et al. (1999) · Nature · doi:10.1038/22313 · Cited by 495
Benfield, P., & Ward, A. (1986) · Drugs · doi:10.2165/00003495-198632040-00002 · Cited by 494
Biomedicinal aspects of fluorine chemistry
Filler, R., 小林, 義., & 日本化学会 (1982) · Medical Entomology and Zoology · Cited by 423
McTaggart, F., Buckett, L., Davidson, R., Holdgate, G., McCormick, A., Schneck, D., Smith, G., & Warwick, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01454-0 · Cited by 413
Biochemical profile of risperidone, a new antipsychotic.
Leysen, J. E., Gommeren, W., Eens, A., de Chaffoy de Courcelles, D., Stoof, J. C., & Janssen, P. A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13416-2 · Cited by 411
Streptogramins, Oxazolidinones, and Other Inhibitors of Bacterial Protein Synthesis
Mukhtar, T. A., & Wright, G. D. (2005) · Chemical Reviews · doi:10.1021/cr030110z · Cited by 371
Reck, F., Zhou, F., Girardot, M., Kern, G., Eyermann, C. J., Hales, N. J., Ramsay, R. R., & Gravestock, M. B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0400810 · Cited by 332
The Discovery of Ezetimibe: A View from Outside the Receptor
Clader, J. W. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030283g · Cited by 325
Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by Pioglitazone
Sakamoto, J., Kimura, H., Moriyama, S., Odaka, H., Momose, Y., Sugiyama, Y., & Sawada, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3868 · Cited by 313
Sznaidman, M. L., Haffner, C. D., Maloney, P. R., Fivush, A., Chao, E., Goreham, D., Sierra, M. L., LeGrumelec, C., Xu, H. E., Montana, V. G., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00207-5 · Cited by 312
Newer Systemic Antifungal Agents: Pharmacokinetics, Safety and Efficacy
Boucher, H. W., Groll, A. H., Chiou, C. C., & Walsh, T. J. (2004) · Drugs · doi:10.2165/00003495-200464180-00001 · Cited by 305
Burke, W. J. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1477 · Cited by 244
Bächner, D., Kreienkamp, H.-J., Weise, C., Buck, F., & Richter, D. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01092-3 · Cited by 201
T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist
Takekawa, S., Asami, A., Ishihara, Y., Terauchi, J., Kato, K., Shimomura, Y., Mori, M., Murakoshi, H., Kato, K., Suzuki, N., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01314-6 · Cited by 200
Borowsky, B., Durkin, M. M., Ogozalek, K., Marzabadi, M. R., DeLeon, J., Heurich, R., Lichtblau, H., Shaposhnik, Z., Daniewska, I., Blackburn, T. P., et al. (2002) · Nature Medicine · doi:10.1038/nm0902-1039b · Cited by 192
Voriconazole: A New Triazole Antifungal
Sabo, J., & Abdel‐Rahman, S. M. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19237 · Cited by 190
Somsak, L., Nagy, V., Hadady, Z., Docsa, T., & Gergely, P. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454919 · Cited by 185
Structure-Based Optimization of Azole Antifungal Agents by CoMFA, CoMSIA, and Molecular Docking
Sheng, C., Zhang, W., Ji, H., Zhang, M., Song, Y., Xu, H., Zhu, J., Miao, Z., Jiang, Q., Yao, J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051211n · Cited by 184
Fried, J., & Sabo, E. F. (1953) · Journal of the American Chemical Society · doi:10.1021/ja01105a527 · Cited by 181
Shimomura, Y., Mori, M., Sugo, T., Ishibashi, Y., Abe, M., Kurokawa, T., Onda, H., Nishimura, O., Sumino, Y., & Fujino, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1104 · Cited by 172
Barter, P. J., & Kastelein, J. J. P. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.042 · Cited by 168
Costantino, L., Rastelli, G., Vianello, P., Cignarella, G., & Barlocco, D. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199901)19:1<3::aid-med2>3.0.co;2-7 · Cited by 159
Clark, R. W., Ruggeri, R. B., Cunningham, D., & Bamberger, M. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500349-jlr200 · Cited by 144
Discovery of Fluconazole, a Novel Antifungal Agent
Richardson, K., Cooper, K., Marriott, M. S., Tarbit, M. H., Troke, F., & WHITTLE, P. J. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.supplement_3.s267 · Cited by 136
Krämer, D. K., Al-Khalili, L., Perrini, S., Skogsberg, J., Wretenberg, P., Kannisto, K., Wallberg-Henriksson, H., Ehrenborg, E., Zierath, J. R., & Krook, A. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1157 · Cited by 132
Current and Novel Approaches to the Drug Treatment of Schizophrenia
Rowley, M., Bristow, L. J., & Hutson, P. H. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0002432 · Cited by 128
Bril, V., Buchanan, R. A., & the Ranirestat Study Group* (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1447 · Cited by 128
Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor
Bischoff, H., Angerbauer, R., Bender, J., Bischoff, E., Faggiotto, A., Petzinna, D., Pfitzner, J., Porter, M. C., Schmidt, D. D., & Thomas, G. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00188-3 · Cited by 110
Keller, M. B. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1202 · Cited by 109
(3-Substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents
Nomura, M., Kinoshita, S., Satoh, H., Maeda, T., Murakami, K., Tsunoda, M., Miyachi, H., & Awano, K. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00039-6 · Cited by 105
Indole-2-carboxamide Inhibitors of Human Liver Glycogen Phosphorylase
Hoover, D. J., Snow, S. L., Burgess‐Henry, J., Martin, W. H., Armento, S. J., Stock, I. A., McPherson, R. K., Genereux, P. E., Gibbs, E. M., & Treadway, J. L. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980264k · Cited by 101
Warn, P. A., Sharp, J., & Denning, D. W. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki399 · Cited by 93
Synthesis and biological evaluations of quinoline-based HMG-CoA reductase inhibitors
Suzuki, M., Iwasaki, H., Fujikawa, Y., Kitahara, M., Sakashita, M., & Sakoda, R. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00198-5 · Cited by 88
Granger, B., & Albu, S. (2005) · Annals of Clinical Psychiatry · doi:10.1080/10401230591002048 · Cited by 82
Acyl Ureas as Human Liver Glycogen Phosphorylase Inhibitors for the Treatment of Type 2 Diabetes
Klabunde, T., Wendt, K. U., Kadereit, D., Brachvogel, V., Burger, H.-J., Herling, A. W., Oikonomakos, N. G., Kosmopoulou, M. N., Schmoll, D., Sarubbi, E., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049034y · Cited by 77
Leibowitz, M. D., Ardecky, R., Boehm, M. F., Broderick, C. L., Carfagna, M. A., Crombie, D. L., D’Arrigo, J., Etgen, G. J., Faul, M. M., Grese, T. A., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0690 · Cited by 73
Champney, W. S., & Burdine, R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.2141 · Cited by 72
New antifungal agents under development in children and neonates
Steinbach, W. J., & Benjamin, D. K. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000185986.64759.9a · Cited by 56
An overview of the animal pharmacology of paroxetine
Johnson, A. M. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07161.x · Cited by 47
Sobue, S., Tan, K., Layton, G. R., Eve, M. D., & Sanderson, J. B. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02107.x · Cited by 36
Kun, E., Kirsten, E., & Sharma, M. L. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4942 · Cited by 35
New drugs for the treatment of hypercholesterolaemia
Iglesias, P., & Díez, J. J. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.11.1777 · Cited by 34
The search for new antimicrobials: why we need new options
Zinner, S. H. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.6.907 · Cited by 33
Carrillo-Muñoz, A.-J., Quindós, G., Ruesga, M., Alonso, R., del Valle, O., Hernández-Molina, J. M., McNicholas, P. M., Loebenberg, D., & Santos, P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki022 · Cited by 31
Oikonomakos, N. G., Zographos, S. E., Skamnaki, V. T., & Archontis, G. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00394-7 · Cited by 30
Structure?Activity Relationships for Three Macrolide Antibiotics in Haemophilus influenzae
Mabe, S., Eller, J., & Champney, W. S. (2004) · Current Microbiology · doi:10.1007/s00284-004-4312-9 · Cited by 29
In Vitro and In Vivo Activities of CS-758 (R-120758), a New Triazole Antifungal Agent
Kamai, Y., Harasaki, T., Fukuoka, T., Ohya, S., Uchida, K., Yamaguchi, H., & Kuwahara, S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.367-370.2002 · Cited by 27
The Effect of Ravuconazole on the Pharmacokinetics of Nelfinavir in Healthy Male Volunteers
Yan, J., Marino, M. R., Smith, R. A., Kanamaluru, V., O'Mara, E. M., & Grasela, D. M. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005283462 · Cited by 14
Emerging Topics in Atherosclerosis: HDL Raising Therapies
Sinclair, P. J. (2005) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(05)40005-6 · Cited by 5
Cited by
Fluorine in Pharmaceuticals: Looking Beyond Intuition
Müller, K., Faeh, C., & Diederich, F. (2007) · Science · doi:10.1126/science.1131943 · Cited by 6,596
Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H. (2014) · Chemical Reviews · doi:10.1021/cr4002879 · Cited by 4,847
The Many Roles for Fluorine in Medicinal Chemistry
Hagmann, W. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800219f · Cited by 3,578
Zhou, Y., Wang, J., Gu, Z., Wang, S., Zhu, W., Aceña, J. L., Soloshonok, V. A., Izawa, K., & Liu, H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00392 · Cited by 2,808
Ilardi, E. A., Vitaku, E., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401375q · Cited by 1,604
Metadata
- Authors
- Kirk, K. L.
- Venue
- Journal of Fluorine Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 127
- Issue
- 8
- Pages
- 1013-1029
- ISSN
- 0022-1139 (ISSN-L)
- OpenAlex
- W2166173570
- Cited by
- 900
- References
- 65
- FWCI
- 28.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.